Panacea Biotec Limited · NSE: PANACEABIO · BSE: 531349
Panacea Biotec
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 13 Aug 2026.
Q1 FY27 · Consolidated
Revenue
199.57₹ Cr
+19.7% vs year ago
Net profit
2.20₹ Cr
−44.4% vs year ago
EPS, basic
0.38₹
−42.4% vs year ago
Net margin
1.1%
−1.3 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 199.57 | +19.7% | 2.20 | −44.4% | 0.38 | 13 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 166.75 | +25.8% | (1.00) | Loss narrowed | 0.08 | 20 Aug 2026 |
| Q3 FY26Oct–Dec 2025 | 165.19 | +1.0% | 3.89 | −12.4% | 0.65 | 11 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 141.13 | −4.2% | (14.01) | Turned loss | (2.27) | 14 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 166.70 | +44.1% | 3.96 | Turned profit | 0.66 | 14 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 132.53 | −2.9% | (1.99) | Unchanged | (0.31) | 30 May 2025 |
| Q3 FY25Oct–Dec 2024 | 163.49 | +8.6% | 4.44 | Turned profit | 0.74 | 14 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 147.35 | +3.0% | 4.71 | Turned profit | 0.77 | 14 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 115.72 | −10.4% | (15.88) | Turned loss | (2.59) | 30 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 136.46 | +5.8% | (1.99) | Loss narrowed | (0.23) | 19 Jul 2024 |
| Q3 FY24Oct–Dec 2023 | 150.50 | +30.6% | (2.20) | Turned loss | (0.37) | 24 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 143.02 | +36.1% | (8.29) | Turned loss | (1.35) | 23 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 129.19 | +16.7% | 10.98 | Turned profit | 1.79 | 12 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 128.93 | −8.4% | (12.68) | Turned loss | (2.07) | 31 May 2023 |
| Q3 FY23Oct–Dec 2022 | 115.20 | −26.1% | 19.37 | Turned profit | 3.16 | 17 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 105.12 | −54.7% | 15.70 | Turned profit | 2.56 | 25 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 110.70 | −16.4% | (56.14) | Loss narrowed | (9.17) | 24 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 140.73 | −16.4% | 1,237.47 | Turned profit | 202.03 | 23 May 2022 |
| Q3 FY22Oct–Dec 2021 | 155.88 | +10.0% | (49.20) | Loss widened | (8.03) | 17 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 232.17 | +27.6% | (53.01) | Loss widened | (8.65) | 13 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 132.45 | −0.2% | (57.35) | Loss widened | (9.36) | 24 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 168.27 | +34.2% | (54.14) | Loss narrowed | (8.84) | 03 Jun 2021 |
| Q3 FY21Oct–Dec 2020 | 141.76 | −15.5% | (40.05) | Loss widened | (6.54) | 12 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 182.02 | +45.4% | (19.33) | Loss narrowed | (3.16) | 16 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 132.76 | +5.5% | (34.13) | Loss widened | (5.58) | 04 Sep 2020 |
| Q4 FY20Jan–Mar 2020 | 125.36 | — | (69.70) | — | (11.38) | 03 Jul 2020 |
| Q3 FY20Oct–Dec 2019 | 167.74 | — | (21.32) | — | (3.48) | 19 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 125.18 | — | (75.00) | — | (12.25) | 19 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 125.78 | — | (28.27) | — | (4.62) | 14 Aug 2019 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 134.71 | +20.0% | 1.39 | Turned profit | 0.23 | 13 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 111.12 | +63.7% | (0.18) | Loss narrowed | (0.03) | 20 Aug 2026 |
| Q3 FY26Oct–Dec 2025 | 99.31 | −8.4% | (7.36) | Turned loss | (1.20) | 11 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 90.81 | +18.5% | (15.64) | Turned loss | (2.55) | 14 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 112.25 | +97.3% | (6.70) | Loss narrowed | (1.09) | 14 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 67.90 | −15.5% | (12.39) | Loss widened | (2.02) | 30 May 2025 |
| Q3 FY25Oct–Dec 2024 | 108.43 | +13.9% | 9.65 | 22x | 1.58 | 14 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 76.64 | −19.0% | 1.29 | −59.7% | 0.21 | 14 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 56.88 | −36.4% | (13.78) | Turned loss | (2.25) | 30 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 80.37 | +7.1% | (1.37) | Loss narrowed | (0.22) | 19 Jul 2024 |
| Q3 FY24Oct–Dec 2023 | 95.23 | +32.3% | 0.43 | −96.8% | 0.07 | 24 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 94.59 | +94.1% | 3.20 | Turned profit | 0.52 | 23 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 89.41 | +45.8% | 1.29 | Turned profit | 0.21 | 12 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 75.02 | +80.8% | (19.69) | Loss narrowed | (3.21) | 31 May 2023 |
| Q3 FY23Oct–Dec 2022 | 71.97 | +87.0% | 13.24 | Turned profit | 2.16 | 17 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 48.74 | −59.1% | (6.85) | Loss narrowed | (1.12) | 25 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 61.34 | +69.2% | (74.24) | Loss widened | (12.12) | 24 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 41.50 | −48.0% | (25.31) | Loss widened | (4.13) | 23 May 2022 |
| Q3 FY22Oct–Dec 2021 | 38.48 | −44.2% | (22.43) | Turned loss | (3.66) | 17 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 119.26 | +0.9% | (22.37) | Turned loss | (3.65) | 13 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 36.26 | −52.6% | (23.47) | Loss widened | (3.83) | 24 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 79.86 | +40.7% | (18.31) | Loss narrowed | (2.99) | 03 Jun 2021 |
| Q3 FY21Oct–Dec 2020 | 69.02 | +24.3% | 1.90 | Turned profit | 0.31 | 12 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 118.20 | +463.4% | 10.81 | Turned profit | 1.76 | 16 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 76.48 | +208.1% | (8.84) | Loss narrowed | (1.45) | 04 Sep 2020 |
| Q4 FY20Jan–Mar 2020 | 56.77 | +94.0% | (32.48) | Turned loss | (5.31) | 03 Jul 2020 |
| Q3 FY20Oct–Dec 2019 | 55.52 | −51.2% | (19.74) | Loss narrowed | (3.23) | 19 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 20.98 | −82.3% | (71.64) | Loss narrowed | (11.70) | 19 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 24.82 | −73.9% | (29.21) | Loss narrowed | (4.77) | 14 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 29.26 | — | 183.90 | — | 30.02 | 12 Jun 2019 |
| Q3 FY19Oct–Dec 2018 | 113.85 | — | (23.02) | — | (3.76) | 16 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 118.58 | — | (97.49) | — | (15.92) | 24 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 95.11 | — | (36.83) | — | (6.01) | 20 Aug 2018 |
62 filings on record for this company.